Archive: 01/09/2015

No benefit to prolonging bivalirudin after PCI

Extending treatment with the anticoagulant bivalirudin for at least four hours after completion of percutaneous coronary intervention (PCI) does not improve outcomes compared to stopping the treatment immediately after the ...

Absorbable matrix does not prevent cardiac remodelling

An investigational material known Bioabsorbable Cardiac Matrix (BCM) that is injected through the coronary artery to prevent cardiac remodelling in heart attack patients had no significant effect compared to a saline placebo, ...

Antiparasitics for Chagas cardiomyopathy

A 40 to 80 day treatment with the antiparasitic medication benznidazole significantly reduced parasite activity in the blood, but not the progression of serious heart problems over a 5-year period among patients with established ...

page 7 from 10